27.07.2015 • NewsDede WillamsArkemaHygiene

Bostik Expands Adhesives Capacity in India

© twixx - Fotolia.com
© twixx - Fotolia.com

As part of its drive to expand in high growth regions, Arkema subsidiary Bostik is expanding its production capacity in Bangalore, India. The French chemical group said the new hot melt pressure sensitive adhesives (HMPSA) production units will enhance Bostik’s ability to supply customers in the disposable hygiene market.

A global player, the German company specializes in adhesives for industrial manufacturing, construction and consumer markets, supplying solutions for applications including elastic attachment, wetness indication and stretch in baby diapers, feminine hygiene and adult incontinence products in particular.

Bostik has been active in India since 2001. The new facility in India following recent plant openings in China, Malaysia and Brazil. A fully automated packing operation will ensure the quality and efficiency required by customers, the company said.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.